CXSL2000224 | IBI102 | IBI102 | Injection | Biological Products(1) | New Drug Application | 2020-08-04 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2020-08-03 | view |
CXSL1900040 | IBI110 | IBI110 | Other | Biological Products(1) | New Drug Application | 2019-04-26 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2019-04-25 | view |
CXSL2000049 | IBI112 | picankibart | Injection | Biological Products(1) | New Drug Application | 2020-03-14 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2020-03-13 | view |
CXSL2000021 | IBI112 | picankibart | Injection | Biological Products(1) | New Drug Application | 2020-02-14 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2020-02-13 | view |
CXSL2000263 | IBI188 | letaplimab | Injection | Biological Products(1) | New Drug Application | 2020-09-12 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2020-09-11 | view |
CXSL1800074 | IBI188 | letaplimab | Injection | Biological Products(1) | New Drug Application | 2018-07-04 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | Certificate Issued | 2018-09-03 | view |
CXSL1900053 | IBI306 | tafolecimab | Injection | Biological Products(1) | New Drug Application | 2019-06-12 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2019-06-10 | view |
CXSL1500136 | IBI308 | sintilimab | Injection | Biological Products(1) | New Drug Application | 2016-01-25 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | Certificate Issued | 2016-09-04 | view |
CXSL2000233 | IBI310 | ipilimumab | Injection | Biological Products(3.3) | New Drug Application | 2020-08-12 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2020-08-11 | view |
CXSL2000231 | IBI310 | ipilimumab | Injection | Biological Products(3.3) | New Drug Application | 2020-08-12 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2020-08-11 | view |
CXSL2000222 | IBI310 | ipilimumab | Injection | Biological Products(3.3) | New Drug Application | 2020-08-04 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2020-08-03 | view |
CXSL2000304 | IBI318 | IBI318 | Injection | Biological Products(1) | New Drug Application | 2020-10-28 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2020-10-27 | view |
CXSL2100029 | IBI318 | IBI318 | Injection | Biological Products(1) | New Drug Application | 2021-01-23 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2021-01-22 | view |
CXSL2000274 | IBI318 | IBI318 | Injection | Biological Products(1) | New Drug Application | 2020-09-28 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2020-09-28 | view |
CXSL1800119 | IBI318 | IBI318 | Injection | Biological Products(1) | New Drug Application | 2018-12-10 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2018-12-07 | view |
CXSL2000255 | IBI319 | IBI319 | Injection | Biological Products(1) | New Drug Application | 2020-09-05 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2020-09-04 | view |
CXSL2100081 | IBI321 | IBI-321 | Injection | Biological Products(1) | New Drug Application | 2021-03-04 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2021-03-03 | view |
CXSL1900125 | IBI322 | IBI322 | Injection | Biological Products(1) | New Drug Application | 2019-11-07 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2019-11-06 | view |
CXSL2000242 | IBI323 | IBI323 | Injection | Biological Products(1) | New Drug Application | 2020-08-25 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2020-08-24 | view |
CXHL2100071 | IBI362注射液 | mazdutide | Injection | Chemical Drugs(1) | New Drug Application | 2021-01-29 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2021-01-28 | view |